Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase II Trial of Trifluridine/Tipiracil Plus Irinotecan in Patients with Advanced, Refractory Biliary Tract Carcinoma.
Tella SH, Foster N, Qian S, Nguyen T, Borad MJ, McWilliams RR, Alberts SR, Wee Ma W, Chakrabarti S, Fruth B, Wessling J, Hartgers M, Washburn L, Fernandez-Zapico ME, Hogenson TL, Pitot H, Jin Z, Mahipal A. Tella SH, et al. Among authors: wessling j. Oncologist. 2023 Oct 3;28(10):917-e966. doi: 10.1093/oncolo/oyad144. Oncologist. 2023. PMID: 37339254 Free PMC article. Clinical Trial.
Phase II Trial of Trifluridine/Tipiracil in Patients with Advanced, Refractory Biliary Tract Carcinoma.
Chakrabarti S, Zemla TJ, Ahn DH, Ou FS, Fruth B, Borad MJ, Hartgers ML, Wessling J, Walkes RL, Alberts SR, McWilliams RR, Liu MC, Durgin LM, Bekaii-Saab TS, Mahipal A. Chakrabarti S, et al. Among authors: wessling j. Oncologist. 2020 May;25(5):380-e763. doi: 10.1634/theoncologist.2019-0874. Epub 2019 Dec 11. Oncologist. 2020. PMID: 31826977 Free PMC article. Clinical Trial.
Safety and Activity of PolyPEPI1018 Combined with Maintenance Therapy in Metastatic Colorectal Cancer: an Open-Label, Multicenter, Phase Ib Study.
Hubbard JM, Tőke ER, Moretto R, Graham RP, Youssoufian H, Lőrincz O, Molnár L, Csiszovszki Z, Mitchell JL, Wessling J, Tóth J, Cremolini C. Hubbard JM, et al. Among authors: wessling j. Clin Cancer Res. 2022 Jul 1;28(13):2818-2829. doi: 10.1158/1078-0432.CCR-22-0112. Clin Cancer Res. 2022. PMID: 35472243 Free PMC article. Clinical Trial.
[Colorectal cancer screening with virtual colonography].
Layer G, Wessling J. Layer G, et al. Among authors: wessling j. Radiologie (Heidelb). 2024 May 13. doi: 10.1007/s00117-024-01321-0. Online ahead of print. Radiologie (Heidelb). 2024. PMID: 38739177 Review. German.
[Hospital Reform].
Wessling J. Wessling J. Rofo. 2024 Mar;196(3):240-242. doi: 10.1055/a-2209-8910. Epub 2024 Feb 21. Rofo. 2024. PMID: 38382502 German. No abstract available.
Application of liver-specific contrast agents for evaluation of focal liver lesions - Expert recommendations from the Gastrointestinal and Abdominal Imaging Workgroup of the German Roentgen Society.
Ringe KI, Fischbach F, Grenacher L, Juchems MS, Kukuk G, Lauenstein T, Wessling J, Schreyer AG. Ringe KI, et al. Among authors: wessling j. Rofo. 2023 Dec 19. doi: 10.1055/a-2192-9921. Online ahead of print. Rofo. 2023. PMID: 38113896 Free article. English, German.
[Autoimmune pancreatitis versus pancreatic cancer].
Wessling J, Juchems M, Grenacher L, Schreyer AG. Wessling J, et al. Radiologie (Heidelb). 2023 Dec;63(12):886-893. doi: 10.1007/s00117-023-01240-6. Epub 2023 Nov 10. Radiologie (Heidelb). 2023. PMID: 37947862 Review. German.
Intestinal MRI in Inflammatory Bowel Disease - Literature and Survey-Based Recommendations regarding Reporting by the German Radiological Society (DRG) and the German Competence Network for Inflammatory Bowel Diseases.
Wessling J, Kucharzik T, Bettenworth D, Luegering A, Maaser C, Grenacher L, Juchems MS, Ringe KI, Lauenstein T, Schreyer AG. Wessling J, et al. Rofo. 2023 Aug;195(8):675-690. doi: 10.1055/a-2036-7190. Epub 2023 May 3. Rofo. 2023. PMID: 37137321 Free article. English, German.
104 results